Neurological complications and loss of efficacy with intrathecal pain therapy. Three case reports and overview of the literature;Neurologische komplikationen und wirkverlust unter intrathekaler schmerztherapie. Drei fallberichte und auswertung der literatur

Schmerz

Volumn 19, Issue 2, 2005, Pages 144-155

  Kindler, D ^a   Maier, C ^a   Kagel, T ^a   Schulz, S ^a   Weiss, T ^a   Zenz, M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Intrathecal pain therapy; Morphine; Neurological complications; Undesired events

Indexed keywords

ANALGESIC AGENT; BROMAZEPAM; CARBAMAZEPINE; CLONIDINE; DIPYRONE; DOXEPIN; HALOPERIDOL; HYDROMORPHONE; MORPHINE; OPIATE;

DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; EXPLANT; FREQUENCY ANALYSIS; HEALTH CENTER; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; NEUROLOGICAL COMPLICATION; PAIN; PATIENT MONITORING; REVIEW; SURGEON;

ADMINISTRATION, ORAL; AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; INJECTIONS, SPINAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PAIN;

EID: 17844406687     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-004-0327-1     Document Type: Review

References (49)

1. Anderson VC, Burchiel KJ (1999) A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 44:289-300
2. Angel I, Gould H, Carey M (1998) Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin. Surg Neurol 49:92-99
3. Bejjani GK, Karim NO, Tzortzidis F (1997) Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol 48:288-291
4. Bennett G, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante FM, Hassenbusch SJ, Lou L, Maeyaert J, Penn R, Portenoy RK, Rauck R, Serafini M, Willis KD, Yaksh T (2000) Clinical guidelines for intraspinal infusion: report of an expert panel. J Pain Symptom Manage 20:37-43
5. Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante FM, Hassenbusch SJ, Lou L, Maeyaert J, Penn R, Portenoy RK, Rauck R, Willis KD, Yaksh T (2000) Evidence-based review of the literature on intrathekal delivery of pain medication. J Pain Symptom Manage 20:12-36
6. Bennett MI, Tai, YMA, Symonds JM (1994) Staphylococcal meningitis following Synchromed intrathecal pump implant: a case report. Pain 56:243-244
7. Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218
8. Blount JP, Remley KP, Yue SK, Erickson PL (1996) Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases. J Neurosurg 84:272-276
9. Cabbell KL, Taren JA, Sagher O (1998) Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery 42:1176-1180
10. Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shelter AG, Levy R, Gill B, Smith R, Wilberger J, Loeser JD, Chabal C, Feler C, Robertson JT, Penn RD, Clarke A, Burchiel KJ, Leibrock LG (1993) Intrathecal baclofen for intractable spasticitiy of spinal orign: Results of a long-term multicenter study. J Neurosurg 78:226-232
11. Dertwinkel R, Donner B, Zenz M, Schulz S, Bading B (1998) Opioids in chronic pain. Baillière's Clin Anaesthesiol 12:39-52
12. Dickerman RD, Schneider SJ (2002) Recurrent intrathecal baclofen pump catheter leakage: a surgical observation with recommendations. J Pediatr Surg 37:E17
13. Follett KA, Naumann CP (2000) A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 19:209-215
14. Foster MR (2002) Piriformis syndrome. Orthopedics 25:821-825
15. Grabow TS, Derdzinski D, Staats PS (2001) Spinal drug delivery. Curr Pain Headache Rep 5(6):510-516
16. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA (1996) Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64:107-114
17. Gybels and the Task Force of the EFIC (1998) Neuromodulation of pain. A consensus statement. Eur J Pain 2:203-209
18. Hardy PA (1994) Extradural blood patch of a cerebrospinal fluid cutaneous fistula in the presence of an intrathecal drug delivery system. Anaesthesiology 81:1299-1300
19. Harke H, Rosenow E, Tronnier V, Fromme C, Deynet G, Gretenkort P, Buschman D, Rohr P, Ladleif HU, von Glinski E, Schutze G, Schultze R, Keller HL, Kniesel B, Pfeifer R, Lux E (2003) Standardisierung invasiver neuromodulatorischer Verfahren. Schmerz 17:44-49
20. Hassenbusch S, Stanton-Hicks M, Covington E, Walsh J, Guthrey D (1995) Long-term infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 10:527-543
21. Jones LL, Tuszynski MH (2001) Chronic intrathecal infusions after spinal cord injury cause scarring and compression. Microsc Res Tech 54:317-324
22. Karavelis A, Foroglou G, Selviaridis P, Fountzilas G (1996) Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. Neurosurgery 39:57-62
23. Kumar K, Kelly M, Pirlot T (2001) Continuous intrathecal morphine treatment for chronic pain of non-malignant etiology: long-term benefits and efficacy. Surg Nerol 55:79-88
24. Kumar K, Hunter G, Demeria DD (2002) Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg 97:803-810
25. Langsam A (1999) Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery 44:689-691
26. Le Breton F, Daviet JC, Monteil J, Vidal J, Munoz M, Dudognon P, Salle JY (2001) Radioisotopic control for baclofen pump catheter failure. Spinal Cord 39:283-285
27. Madsen JR (2000) Procedures for intrathecal pharmacological therapy. In: Kaye AH, Leg PM (eds) Operative Neurosurgery. Churchill Livingstone, London, pp 1506-1511
28. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G for the MONTAS Study Group (2002) Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumour associated pain - results of a double-blind placebo-controlled trial (MONTAS). Pain 97:223-233
29. Maier C, Zenz M (2003) Leitlinien - Leitplanken (Editorial). Schmerz 17:1-3
30. Müller H (1992) Treatment of severe spasticity: results of a mulicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantabledrug delivery system. In: Lakke JP, Delhaas EM, Rutgers AWF (eds) Parenteral drug therapy in spasicity and Parkinson's disease. Parthenon, Lancs, pp 103-113
31. Müller H, Zierski J (1989) Long-term continuous intrathecal baclofen infusion. In: Marsden D (ed) Treating spasticity: pharmacological advances. Huber, Basel, pp 55-68
32. Ochs GA, Reimann IW (1995) Baclofen intrathekal. Leitformen für die praktische Anwendung. Thieme, Stuttgart
33. Paice JA, Winkelmüller W, Burchiel K, Racz GB, Prager JP (1997) Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage 14:14-26
34. Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77:236-240
35. Penn RD, York MM, Paice JA (1995) Catheter systems for intrathecal drug delivery. J Neurosurg 83:215-217
36. Schimpf J, Krakow K, Vehreschild N, Pohlmann-Eden B (1999) Transverse myelopathy as a complication following long-term intrathecal application of morphine in chronic back pain. Anasth Intensivmed Notfallmed Schmerzther 34:506-509
37. Schofferman J (1999) Long-term opioid analgesic therapy for severe refractory lumbar spine pain. Clin J Pain 15:136-140
38. Schuchard M, Lanning Rosellen RN, North R, Reig E, Kramer E (1998) Neurologic sequelae of intraspinal drug delivery systems: results of an American implanters of implantable drug delivery systems. Neuromodulation 1:137-148
39. Schulzeck S, Gleim M, Maier C (1993) Morphintabletten bei chronischen nicht-tumorbedingten Schmerzen. Anaesthesist 42:545-556
40. Schurch B (1993) Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report. Paraplegia 31:611-615
41. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE (2002) Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20:4040-4049
42. Sorgatz H, Hege-Scheuing G, Kopf A, Maier C, Sabatowski R, Schäfer M, Stein C, Tölle T, Willweber-Strumpf A (2002) Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen. Dtsch Ärztebl 33:A-2180/B-1851/C-1743
43. Stamer U, Mpasios N, Stüber F, Laubenthal H, Maier C (2002) Postoperative Schmerztherapie in Deutschland. Anaesthesist 51:248-257
44. Teddy P, Jamous A, Gardner B, Wang D, Silver J (1992) Complications of intrathecal baclofen delivery. Br J Neurosurg 6:115-118
45. Trinks MS, Turin I (2000) Abdominelles subcutanes Liquorkissen nach Katheter-Pumpen-Diskonnektion bei intrathekaler Morphinapplikation. Schmerz 14:35-36
46. Velarde CA, Zuniga RE, Leon RF, Abram SE (2000) Cranial nerve palsy and intracranial subdural hematoma following implantation of intrathecal drug delivery device. Reg Anesth Pain Med 25:76-78
47. Wallace M, Yaksh TL (2000) Long-term spinal analgesic delivery: a review of the preclinic and clinical literature. Reg Anaesth Pain Med 25:117-157
48. Wallace MS (2002) Treatment options for refractory pain. The role of intrathecal therapy. Neurology 59:18-24
49. Winkelmüller M, Winkelmüller W (1996) Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 85:458-467